Yini Xu Selected Research

Cicatrix (Scar)

12/2018

Toll-like receptor 4 contributes to a myofibroblast phenotype in cardiac fibroblasts and is associated with autophagy after myocardial infarction in a mouse model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yini Xu Research Topics

Disease

6	Neoplasms (Cancer) 12/2023 - 01/2019
6	Fibrosis (Cirrhosis) 07/2019 - 03/2012
5	Myocardial Infarction 12/2018 - 03/2012
3	Cardiovascular Diseases (Cardiovascular Disease) 08/2023 - 10/2017
3	Diabetic Cardiomyopathies 08/2023 - 01/2020
2	Colorectal Neoplasms (Colorectal Cancer) 10/2023 - 01/2021
2	Diabetic Retinopathy (Retinopathy, Diabetic) 08/2023 - 01/2020
2	Infections 04/2021 - 12/2019
2	Squamous Cell Carcinoma of Head and Neck 01/2021 - 11/2019
1	Hepatitis 01/2023
1	Reperfusion Injury 10/2022
1	Hypoxia (Hypoxemia) 09/2022
1	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 09/2022
1	Cognitive Dysfunction 09/2022
1	Adenoviridae Infections (Adenovirus Infections) 01/2022
1	Type 2 Diabetes Mellitus (MODY) 01/2022
1	Cardiomyopathies (Cardiomyopathy) 01/2022
1	Wounds and Injuries (Trauma) 01/2022
1	Carcinoma (Carcinomatosis) 01/2021
1	Gliosis 01/2020
1	Diabetes Complications 01/2020
1	Bacterial Infections (Bacterial Infection) 03/2019
1	Breast Neoplasms (Breast Cancer) 01/2019
1	Neoplasm Metastasis (Metastasis) 01/2019
1	Glioblastoma (Glioblastoma Multiforme) 01/2019
1	Carcinogenesis 01/2019
1	Cicatrix (Scar) 12/2018
1	Hypertension (High Blood Pressure) 11/2017
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 11/2017
1	Diabetes Mellitus 10/2017
1	Heart Failure 10/2017
1	Infarction (Infarctions) 08/2015

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 10/2023 - 01/2014
4	oxymatrineIBA 01/2021 - 03/2012
3	Volatile Oils (Essential Oils)IBA 08/2023 - 10/2017
3	Anti-Infective Agents (Microbicides)IBA 04/2021 - 03/2019
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 08/2023 - 01/2020
2	AntioxidantsIBA 08/2023 - 01/2020
2	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 10/2017
2	cyclovirobuxine DIBA 01/2022 - 01/2020
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2020
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 11/2019
2	Transforming Growth Factor beta (TGF-beta)IBA 08/2015 - 03/2012
2	oxidized low density lipoproteinIBA 11/2014 - 01/2014
2	Messenger RNA (mRNA)IBA 01/2014 - 03/2012
1	Tryptophan (L-Tryptophan)FDA Link 12/2023
1	Peptides (Polypeptides)IBA 12/2023
1	OligosaccharidesIBA 12/2023
1	Immunologic Factors (Immunomodulators)IBA 12/2023
1	Prion ProteinsIBA 10/2023
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 10/2023
1	Sirtuin 1IBA 08/2023
1	EucalyptolIBA 08/2023
1	tanshinoneIBA 08/2023
1	Transaminases (Aminotransferases)IBA 01/2023
1	Concanavalin AIBA 01/2023
1	Therapeutic UsesIBA 01/2023
1	Phosphates (Orthophosphate)IBA 01/2023
1	Propofol (Diprivan)FDA LinkGeneric 10/2022
1	bardoxoloneIBA 09/2022
1	gastrodinIBA 09/2022
1	Small Interfering RNA (siRNA)IBA 01/2022
1	Histones (Histone)IBA 01/2022
1	Streptozocin (Streptozotocin)FDA Link 01/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	Retinaldehyde (Retinal)IBA 01/2020
1	AldosteroneIBA 07/2019
1	CurcuminIBA 07/2019
1	SilverIBA 03/2019
1	Extracellular Matrix ProteinsIBA 01/2019
1	FlavonoidsIBA 01/2019
1	Cadherins (E-Cadherin)IBA 01/2019
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2019
1	VimentinIBA 01/2019
1	Tumor Viral Antigens (Large T Antigen)IBA 01/2019
1	baicaleinIBA 01/2019
1	Fibronectins (Fibronectin)IBA 01/2019
1	Toll-Like Receptor 4IBA 12/2018
1	Autophagy-Related ProteinsIBA 12/2018
1	Angiotensin IIIBA 10/2018
1	prolinedithiocarbamate (PDTC)IBA 10/2018
1	salvianolic acid BIBA 10/2018
1	Annexin A5IBA 11/2017
1	2- (2- amino- 3- methoxyphenyl)- 4H- 1- benzopyran- 4- oneIBA 10/2017
1	pyrazolanthroneIBA 10/2017
1	Collagen Type III (Type III Collagen)IBA 10/2017
1	SB 203580IBA 10/2017
1	AlkaloidsIBA 07/2016
1	Ginkgo biloba extract (Rokan)IBA 08/2015
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 08/2015
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 08/2015
1	Collagen Type I (Type I Collagen)IBA 08/2015
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 08/2015
1	salicylhydroxamic acid (SHAM)IBA 08/2015

Therapy/Procedure

3	Therapeutics 01/2021 - 10/2017
3	Ligation 10/2017 - 03/2012
1	Immunotherapy 12/2023
1	Drug Therapy (Chemotherapy) 01/2021